Metabolic
Semaglutide
GLP-1 analog / Ozempic / Wegovy / Rybelsus
- Peptide length
- 31 amino acids
Acylated peptide analog
Research contextDefined therapeutic evidence
Read the linked studies for their methods and limitations.
A long-acting GLP-1 receptor agonist used in regulated medicines. Oral and injectable products have different formulations and labeled uses.
- Family
- Incretin analog
- Research frame
- GLP-1 receptor
- Molecular format
- Acylated peptide analog
- Formula in linked identity record
- C187H291N45O59
Read the evidence
Use the current label for the exact product and population. A trial of a finished medicine does not establish equivalence for a research vial or semaglutide salt.
Resolve the identity
Confirm the modified sequence, acylation, counterion and formulation. Semaglutide base and salt forms must not be treated as interchangeable.